Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide Ratio

Elevations in the Fasting Serum Proinsulin–to–C-Peptide Ratio Precede the Onset of Type 1 Diabetes

(2016) Emily K. Sims et al.   DIABETES CARE

The relationship between BMI and insulin resistance and progression from single to multiple autoantibody positivity and type 1 diabetes among TrialNet Pathway to Prevention participants

(2016) Farah A. Meah et al.   DIABETOLOGIA

Proinsulin and heat shock protein 90 as biomarkers of beta-cell stress in the early period after onset of type 1 diabetes

(2016) Renecia A. Watkins et al.   Translational Research

Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association

(2015) Richard A. Insel et al.   DIABETES CARE

Predictors of Progression From the Appearance of Islet Autoantibodies to Early Childhood Diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY)

(2015) Andrea K. Steck et al.   DIABETES CARE

Relationship between glycaemic variability and hyperglycaemic clamp-derived functional variables in (impending) type 1 diabetes

(2015) Annelien Van Dalem et al.   DIABETOLOGIA

Hyperglycemic Clamp and Oral Glucose Tolerance Test for 3-Year Prediction of Clinical Onset in Persistently Autoantibody-Positive Offspring and Siblings of Type 1 Diabetic Patients

(2015) Eric V. Balti et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

HbA1cPredicts Time to Diagnosis of Type 1 Diabetes in Children at Risk

(2014) Olli Helminen et al.   DIABETES

Insulin secretion and sensitivity in the prediction of type 1 diabetes in children with advanced β-cell autoimmunity

(2013) Heli T Siljander et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Predictors of progression to Type 1 diabetes: preparing for immune interventions in the preclinical disease phase

(2013) Frans K Gorus et al.   Expert Review of Clinical Immunology

Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in Children

(2013) Anette G. Ziegler et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients

(2012) F. K. Gorus et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Primary and secondary prevention of Type 1 diabetes

(2012) J. S. Skyler   DIABETIC MEDICINE

Age of Islet Autoantibody Appearance and Mean Levels of Insulin, but Not GAD or IA-2 Autoantibodies, Predict Age of Diagnosis of Type 1 Diabetes: Diabetes Autoimmunity Study in the Young

(2011) A. K. Steck et al.   DIABETES CARE

A historical view from thirty eventful years of immunotherapy in autoimmune diabetes

(2011) Jean-François Bach et al.   SEMINARS IN IMMUNOLOGY

Concomitant Enzyme-Linked Immunosorbent Assay Measurements of Rat Insulin, Rat C-Peptide, and Rat Proinsulin from Rat Pancreatic Islets: Effects of Prolonged Exposure to Different Glucose Concentrations

(2010) Annika Carlsson et al.   ENDOCRINOLOGY

Predictive power of screening for antibodies against insulinoma-associated protein 2 beta (IA-2β) and zinc transporter-8 to select first-degree relatives of type 1 diabetic patients with risk of rapid progression to clinical onset of the disease: implications for prevention trials

(2009) J. De Grijse et al.   DIABETOLOGIA

Hyperglycaemic clamp test for diabetes risk assessment in IA-2-antibody-positive relatives of type 1 diabetic patients

(2009) E. Vandemeulebroucke et al.   DIABETOLOGIA

Simultaneous Measurement of Plasma Concentrations of Proinsulin and C-Peptide and Their Ratio with a Trefoil-Type Time-Resolved Fluorescence Immunoassay

(2008) P. E.M. De Pauw et al.   CLINICAL CHEMISTRY

Total error profiling of a proinsulin time-resolved fluorescence immunoassay

(2008) P.E. De Pauw et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES